Uncategorized
‘We tested the Indian mutation this week as well, and our vaccine is effective against the Indian variant in the range of 25-30 percent. We expect this effect to 70-75 percent infection protection.’ -Michelle Solly Tweet
Today, 11:05 PM
Michelle SollyMichelle Solly
Uncategorized
Pfizer To Start Making COVID-19 Vaccine Component In Ireland By 2021 End
Today, 11:05 PM
Pfizer Inc (NYSE: PFE) will begin producing an essential ingredient for its COVID-19 vaccine developed in partnership with BioNTech SE (NASDAQ:…
Uncategorized
‘G20 snubs COVID patent waiver, waters down pledge on WHO’s funding’ -Reuters Report
Today, 11:05 PM
https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-g20-snubs-covid-patent-waiver-waters-down-pledge-whos-funding-draft-2021-05-18/?taid=60a3b800ee4f3e0001b3aad8&utm_campaign=trueAnthem:+Trending+Co
Uncategorized
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Today, 11:05 PM
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 10)
Uncategorized
64 Biggest Movers From Yesterday
Today, 11:05 PM
Gainers
InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday.
Uncategorized
What’s Going On With Novavax Stock?
Today, 11:05 PM
Novavax, Inc (NASDAQ: NVAX) shares fell over 12% in the after-hours trading on Monday after closing almost 8.8% lower in regular trading.
Uncategorized
Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15
Today, 11:05 PM
The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years.
Uncategorized
FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children
Today, 11:05 PM
The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10